Rating Change
Piper Sandler reiterated its Overweight rating on Gossamer Bio, Inc. (NASDAQ:GOSS) on August 14, 2026.
reiterateNASDAQ:GOSS
Piper Sandler Reiterates Overweight Rating on Gossamer Bio, Inc. (GOSS)
Piper Sandler reiterated its Overweight rating on Gossamer Bio, Inc. (NASDAQ:GOSS) on August 14, 2026.
At publication ·
What changed
Gossamer Bio, Inc. (NASDAQ:GOSS) · reiterate
- Firm
- Piper Sandler
- Rating
- Overweight to Overweight
- Price at event
- $0.15
- Market capitalization
- $824.3M
At a glance
Key takeaways
- Piper Sandler reiterated an Overweight rating on Gossamer Bio (GOSS) on August 14, 2026, with the stock trading at $0.15 and a market capitalization of $824.3 million.
Market Context
Gossamer Bio, Inc. operates in the Healthcare sector. The stock currently trades at $0.15 with a market capitalization of $824.3M. The stock has declined 92.2% over the past 52 weeks.
Analyst coverage from Piper Sandler provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Gossamer Bio, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Gossamer Bio, Inc.
Among the 10 most recent ratings: 7 Buy, 2 Hold, 1 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 14, 2026 | Piper Sandler | Overweight | N/A |
| Jul 28, 2026 | Leerink Partners | Outperform | N/A |
| Jul 27, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jun 25, 2026 | HC Wainwright & Co. | Buy | N/A |
| May 26, 2026 | HC Wainwright & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View GOSS Stock Page
Frequently Asked Questions
What does the Overweight rating mean for GOSS?
A rating of Overweight from Piper Sandler reflects the analyst's outlook on Gossamer Bio, Inc. (NASDAQ:GOSS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the GOSS forecast page.